Strathclyde, United Kingdom

Andrew David Cunningham


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 105(Granted Patents)


Location History:

  • Strathclyda, GB (2001)
  • Strathclyde, GB (2003)

Company Filing History:


Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cardiac Surgery: The Contributions of Andrew David Cunningham

Introduction

Andrew David Cunningham is a notable inventor based in Strathclyde, GB. He has made significant contributions to the field of medical technology, particularly in the development of ablation catheters used in heart surgery. With a total of 2 patents to his name, Cunningham's work has the potential to enhance surgical procedures and improve patient outcomes.

Latest Patents

Cunningham's latest patents focus on advanced ablation catheters. The first patent describes an ablation catheter that includes a probe, an electrode mounted on the probe, and a remote-operated actuator for moving the electrode. This design allows for precise control during surgical procedures. The second patent elaborates on a similar ablation catheter, detailing its construction with an electrically insulating probe, a tubular electrode, and a flexible insulating sheath. This innovative design enables the creation of long endocardial lesions in cardiac chambers through the application of radio frequency current.

Career Highlights

Cunningham is currently employed at C. R. Bard, Inc., a company known for its advancements in medical devices. His work at the company has allowed him to focus on developing technologies that improve surgical techniques and patient care. His contributions have been instrumental in pushing the boundaries of what is possible in cardiac surgery.

Collaborations

Cunningham collaborates with John Mark Morgan, a fellow innovator in the field. Their partnership has fostered a creative environment that encourages the development of groundbreaking medical technologies.

Conclusion

Andrew David Cunningham's innovations in ablation catheter technology represent a significant advancement in cardiac surgery. His patents and work at C. R. Bard, Inc. highlight his commitment to improving medical procedures and patient safety. The impact of his contributions will likely be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…